Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro
Background/Aims: estrogens and phytoestrogens exert hepatoprotection through mechanisms not clearly examined yet. Here, we investigated the protective effects exerted by 17β-estradiol and genistein against oxidative stress in hepatocytes and hepatic stellate cells (HSCs) and the involvement of specific receptors and the intracellular signalling. Methods: Huh7.5 and LX-2, alone or in co-culture with Huh7.5, were treated with 17β-estradiol and genistein alone or in the presence of menadione and of estrogen receptors (ERs) and G protein-coupled-estrogenic-receptors (GPER) blockers. Cell viability, mitochondrial membrane potential and oxidant/antioxidant system were measured by specific kits. Western Blot was used for the analysis of Akt and p38-mitogen-activated-protein kinases (MAPK) activation and α-smooth-muscle actin expression. Results: In Huh7.5, 17β-estradiol and genistein prevented the effects of peroxidation by modulating Akt and p38MAPK activation. Similar antioxidant and protective findings were obtained in LX-2 of co-culture experiments, only. ERs and GPER blockers were able to prevent the effects of 17β-estradiol and genistein. Conclusion: In Huh7.5 and LX-2, 17β-estradiol and genistein counteract the effects of peroxidation through the involvement of ERs and GPER and by an intracellular signalling related to Akt and p38MAPK. As concerning LX-2, paracrine factors released by Huh7.5 play a key role in protection against oxidative stress.
Top-30
Journals
|
1
2
3
4
|
|
|
International Journal of Molecular Sciences
4 publications, 11.76%
|
|
|
Skin Pharmacology and Physiology
1 publication, 2.94%
|
|
|
International Journal of Molecular Medicine
1 publication, 2.94%
|
|
|
Nutrients
1 publication, 2.94%
|
|
|
Biology
1 publication, 2.94%
|
|
|
Plants
1 publication, 2.94%
|
|
|
Cancers
1 publication, 2.94%
|
|
|
Frontiers in Endocrinology
1 publication, 2.94%
|
|
|
Frontiers in Physiology
1 publication, 2.94%
|
|
|
Frontiers in Medicine
1 publication, 2.94%
|
|
|
Cell Biochemistry and Biophysics
1 publication, 2.94%
|
|
|
Molecular Metabolism
1 publication, 2.94%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 2.94%
|
|
|
PLoS ONE
1 publication, 2.94%
|
|
|
Pharmacological Research
1 publication, 2.94%
|
|
|
Chemico-Biological Interactions
1 publication, 2.94%
|
|
|
Biochemical Pharmacology
1 publication, 2.94%
|
|
|
Journal of Ethnopharmacology
1 publication, 2.94%
|
|
|
Phytotherapy Research
1 publication, 2.94%
|
|
|
Annual Review of Pharmacology and Toxicology
1 publication, 2.94%
|
|
|
Aging Male
1 publication, 2.94%
|
|
|
Journal of Complementary and Integrative Medicine
1 publication, 2.94%
|
|
|
JAMA network open
1 publication, 2.94%
|
|
|
Oxidative Medicine and Cellular Longevity
1 publication, 2.94%
|
|
|
Rejuvenation Research
1 publication, 2.94%
|
|
|
Cytokine
1 publication, 2.94%
|
|
|
Mendeleev Communications
1 publication, 2.94%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
MDPI
8 publications, 23.53%
|
|
|
Elsevier
7 publications, 20.59%
|
|
|
Frontiers Media S.A.
3 publications, 8.82%
|
|
|
Springer Nature
2 publications, 5.88%
|
|
|
S. Karger AG
1 publication, 2.94%
|
|
|
Spandidos Publications
1 publication, 2.94%
|
|
|
Public Library of Science (PLoS)
1 publication, 2.94%
|
|
|
Wiley
1 publication, 2.94%
|
|
|
Annual Reviews
1 publication, 2.94%
|
|
|
Taylor & Francis
1 publication, 2.94%
|
|
|
Walter de Gruyter
1 publication, 2.94%
|
|
|
American Medical Association (AMA)
1 publication, 2.94%
|
|
|
Hindawi Limited
1 publication, 2.94%
|
|
|
IntechOpen
1 publication, 2.94%
|
|
|
Mary Ann Liebert
1 publication, 2.94%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.94%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.